Kim, Kimberly H
Kim, Woojin
Howard, Thomas P
Vazquez, Francisca
Tsherniak, Aviad
Wu, Jennifer N
Wang, Weishan
Haswell, Jeffrey R
Walensky, Loren D
Hahn, William C
Orkin, Stuart H
Roberts, Charles W M
Article History
Received: 7 October 2014
Accepted: 8 September 2015
First Online: 9 November 2015
Competing interests
: L.D.W. is a scientific advisory board member and consultant for Aileron Therapeutics. Via the Dana-Farber Cancer Institute Novartis Drug Discovery Program, C.W.M.R. and W.C.H. receive research support and consulting fees from the Novartis Institutes for Biomedical Research.